Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series

Australas J Dermatol. 2024 Dec 31. doi: 10.1111/ajd.14409. Online ahead of print.

Authors

Conor Larney^{1

2}, Peter Foley^{1

2

3}, Kurt Gebauer^{4

5}, Benjamin S Daniel^{1

6}

Affiliations

¹ Department of Dermatology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
² Skin Health Institute, Carlton, Victoria, Australia.
³ The University of Melbourne, Parkville, Victoria, Australia.
⁴ Fremantle Dermatology, Fremantle, Western Australia, Australia.
⁵ The University of Western Australia, Nedlands, Western Australia, Australia.
⁶ Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

PMID: 39739520
DOI: 10.1111/ajd.14409

No abstract available

Keywords: infliximab; intravenous; psoriasis; subcutaneous.